首页 > 市场调查报告书 > 医疗设备

医学影像诊断内视镜检查设备

市场调查报告书

商品编码

1606511

全球柔性内视镜市场 - 2024-2031

Global Flexible Endoscopy Market - 2024-2031

出版日期: 2024年12月04日 | 出版商:

DataM Intelligence | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

2023年，全球柔性内视镜市场规模达到75.6亿美元，预计2031年将达到117.3亿美元，2024-2031年预测期间复合年增长率为5.7%。

柔性内视镜检查是一种医疗程序，涉及使用称为内视镜的柔性长而细的管子来目视检查身体的内部器官和腔体。这项技术允许医疗保健专业人员诊断、治疗或监测各种病症，而无需大切口，使其成为一种微创手术。内视镜配备光源、摄影机，有时还配备仪器通道以进行干预。与传统手术不同，柔性内视镜手术切口较小或根本没有切口，从而减少了患者的风险、疼痛和恢復时间。

受慢性病发病率增加、内视镜技术进步、微创手术的日益采用以及全球医疗保健意识不断提高等因素的推动，柔性内视镜市场正在经历各种医学专业的巨大需求。胃肠道疾病，包括大肠直肠癌、发炎性肠道疾病（IBD）和胃食道逆流（GERD），是柔性内视镜需求的主要驱动力。例如，根据美国国立卫生研究院的说法，透过诊断和管理，内视镜检查在几乎所有胃肠道疾病中都发挥作用。据估计，美国每年进行超过 2,000 万次胃肠道内视镜检查。

市场动态：

驱动程式和限制

人们越来越偏好微创手术

对微创手术日益增长的偏好极大地推动了柔性内视镜市场的成长，预计将在预测期内推动该市场的发展。使用柔性内视镜进行的微创手术需要较小的切口或根本不需要切口，对身体造成的创伤较小。与传统手术相比，这可以使患者恢復更快并减少疼痛。

例如，在结肠镜检查中，该过程涉及透过直肠插入柔性内视镜。与接受结肠癌诊断的开放手术相比，患者通常恢復得更快，不适也更少。

柔性内视镜越来越多地用于癌症筛检，例如大肠直肠癌的大肠镜检查，这是微创手术的关键应用。早期发现并去除癌前生长物可以减少以后对更具侵入性的治疗的需要，使柔性内视镜检查成为首选。

例如，根据世界癌症研究基金会的数据，2022 年有 1,926,425 例大肠直肠癌新病例。透过大肠镜检查进行筛检可以及早发现并切除息肉，因此无需进行更具侵入性的治疗。

软式内视镜费用高

柔性内视镜的高成本是阻碍柔性内视镜市场成长的一个重要因素，因为它给医疗保健提供者和患者都带来了挑战。这些成本的几个方面，包括设备购买、维护和手术费用，影响内视镜手术的可及性和可负担性，限制了其广泛采用。

柔性内视镜是复杂的设备，需要高品质的组件，例如高清摄影机、光纤电缆、光源和先进的影像处理系统。这些功能导致内视镜设备的购买成本较高，具体取决于规格。例如，据波士顿科学公司称，再处理一台柔性内视镜的总成本为 114.07 美元至 280.71 美元。

Flexible endoscopy is a medical procedure that involves the use of a flexible, long and thin tube known as an endoscope to visually examine the internal organs and cavities of the body. This technique allows healthcare professionals to diagnose, treat or monitor various conditions without the need for large incisions, making it a form of minimally invasive surgery. The endoscope is equipped with a light source, a camera and sometimes instrument channels to perform interventions. Unlike traditional surgery, flexible endoscopy involves smaller incisions or no incisions at all, reducing risks, pain and recovery time for patients.

The flexible endoscopy market is experiencing significant demand across a variety of medical specialties, driven by factors such as increasing incidence of chronic diseases, advancements in endoscopic technology, growing adoption of minimally invasive procedures and rising healthcare awareness globally. GI disorders, including colorectal cancer, inflammatory bowel disease (IBD) and gastroesophageal reflux disease (GERD), are major drivers for the demand for flexible endoscopy. For instance, according to the NIH, through diagnosis and management, endoscopy plays a role in nearly all GI diseases. It is estimated that more than 20 million GI endoscopies are performed yearly in the United States.

Market Dynamics: Drivers & Restraints

Growing preference for minimally invasive procedures

Growing preference for minimally invasive procedures is significantly driving the growth of the flexible endoscopy market and is expected to drive the market over the forecast period. Minimally invasive procedures performed using flexible endoscopes require smaller incisions or no incisions at all, resulting in less trauma to the body. This leads to faster recovery and reduced pain for patients compared to traditional surgeries.

For instance, in colonoscopy, the procedure involves a flexible endoscope inserted through the rectum. Patients typically recover much faster and with less discomfort than if they underwent an open surgery for colon cancer diagnosis.

The flexible endoscope is increasingly used in cancer screening, such as colonoscopy for colorectal cancer, which is a key application of minimally invasive procedures. Early detection and removal of precancerous growths reduce the need for more invasive treatments later on, making flexible endoscopy a preferred choice.

For instance, according to the World Cancer Research Fund, there were 1,926,425 new cases of colorectal cancer in 2022. Colorectal cancer is one of the most common cancers worldwide. Screening with colonoscopy allows for early detection and polyp removal, preventing the need for more invasive treatments.

High cost of flexible endoscopy

The high cost of flexible endoscopy is a significant factor hampering the growth of the flexible endoscopy market, as it presents challenges for both healthcare providers and patients. Several aspects of these costs including equipment purchase, maintenance and procedural expenses impact the accessibility and affordability of endoscopic procedures, limiting their widespread adoption.

Flexible endoscopes are sophisticated devices that require high-quality components, such as high-definition cameras, fiber-optic cables, light sources and advanced image processing systems. These features contribute to the high purchase cost of endoscopy equipment, depending on the specifications. For instance, according to Boston Scientific, the overall cost of reprocessing one flexible endoscope ranged from $114.07 to $280.71.

Segment Analysis

The global flexible endoscopy market is segmented based on product type, application, end-user and region.

Application:

The gastroenterology segment is expected to dominate the global flexible endoscopy market share

The gastroenterology segment holds a major portion of the flexible endoscopy market share and is expected to continue to hold a significant portion of the market share over the forecast period primarily driven by the high prevalence of gastrointestinal (GI) disorders, the increasing demand for early detection and screening of GI diseases and the use of minimally invasive procedures for both diagnostic and therapeutic purposes.

Gastrointestinal disorders, including colorectal cancer, irritable bowel syndrome (IBS), gastroesophageal reflux disease (GERD), and inflammatory bowel disease (IBD) are widespread globally. Flexible endoscopy plays a crucial role in diagnosing and managing these conditions, making gastroenterology the largest segment in the market.

For instance, according to the World Gastroenterology Organisation, While GI diseases remained very common (incidence 7.3 billion cases - largely due to enteric infections) and important (8 million deaths - cirrhosis a major factor) prevalence remained stable. Overall, 49% of females and 36.6% of males met the criteria for at least one functional gastrointestinal disorder - the most common disorders in all regions being functional constipation, functional dyspepsia, proctalgia fugax, functional diarrhea and IBS at prevalence rates of 11.7%, 7.2%, 5.9%, 4.7% and 4.1, respectively.

Additionally, Colorectal cancer (CRC) is one of the most common cancers worldwide, with about 1,926,425 new cases of colorectal cancer in 2022, and colonoscopy remains the gold standard for early detection. Flexible sigmoidoscopy and colonoscopy are key procedures used in the diagnosis and prevention of colorectal cancer.

North America is expected to hold a significant position in the global flexible endoscopy market

North America region is expected to hold the largest market share over the forecast period. North America, particularly the United States, is known for its state-of-the-art healthcare infrastructure, which includes hospitals, clinics and diagnostic centers equipped with the latest medical technologies, including advanced flexible endoscopes. The widespread adoption of high-definition flexible endoscopes, AI-assisted colonoscopy systems and robotic-assisted endoscopy technologies has significantly enhanced the accuracy and efficacy of endoscopic procedures in North America.

North America has some of the highest healthcare spending globally, particularly in the United States. For instance, according to the U.S. Centers for Medicare & Medicaid Services, U.S. healthcare spending grew 4.1 percent in 2022, reaching $4.5 trillion or $13,493 per person. As a share of the nation's Gross Domestic Product, health spending accounted for 17.3 percent. This high spending allows for the procurement of advanced medical devices, including flexible endoscopes.

North America has well-established cancer screening programs, particularly for colorectal cancer. The U.S. Preventive Services Task Force and other healthcare bodies recommend regular colonoscopy screenings for individuals over the age of 50. These screenings contribute significantly to the volume of flexible endoscopy procedures performed in the region.

For instance, according to the National Institute of Health, in the United States, the most commonly used colorectal cancer screening test was colonoscopy, with an estimated 61% of adults aged 50-75 years reporting colonoscopy use within the past 10 years, further fueling the demand for flexible endoscopy in the region.

Asia Pacific is growing at the fastest pace in the flexible endoscopy market

The Asia Pacific region is experiencing the fastest growth in the flexible endoscopy market. The prevalence of gastrointestinal diseases such as colorectal cancer (CRC), gastroesophageal reflux disease (GERD) and inflammatory bowel diseases (IBD) is rising in the Asia Pacific region, leading to an increased demand for flexible endoscopic procedures.

For instance, in China, colorectal cancer is also one of the most commonly diagnosed cancers. A recent study showed that colorectal cancer ranks second in incidence and fourth in mortality, with 408,000 cases and 196,000 deaths, and remains a major public health problem, this growing incidence of GI cancers drives demand for early detection through colonoscopy and other endoscopic procedures.

Competitive Landscape

The major global players in the flexible endoscopy market Becton, Dickinson and Company, KARL STORZ, Olympus Corporation, FUJIFILM Holdings Corporation, Boston Scientific Corporation, Richard Wolf GmbH, ATMOS MedizinTechnik GmbH & Co. KG, LABORIE MEDICAL TECHNOLOGIES CORP., EndoMed Systems GmbH, Entermed and among others.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global flexible endoscopy market report would provide approximately 62 tables, 53 figures and 197 pages.

Target Audience 2023

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Application
3.3. Snippet by End-User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Growing Preference for Minimally Invasive Procedures
  - 4.1.1.2. Technological Advancements in Endoscopic Systems
- 4.1.2. Restraints
  - 4.1.2.1. High Cost of Flexible Endoscopy
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Patent Analysis
5.5. Regulatory Analysis
5.6. SWOT Analysis
5.7. Unmet Needs

6. By Product Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 6.1.2. Market Attractiveness Index, By Product Type
6.2. Gastroscopes*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Colonoscopes
6.4. Enteroscopes
6.5. Duodenoscopes
6.6. Bronchoscopes
6.7. Echoendoscopes
6.8. Others

7. By Application

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 7.1.2. Market Attractiveness Index, By Application
7.2. Gastroenterology*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Pulmonology
7.4. Gynecology
7.5. Urology
7.6. Others

8. By End-User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 8.1.2. Market Attractiveness Index, By End-User
8.2. Hospitals*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Specialty Clinics
8.4. Ambulatory Surgical Centers
8.5. Diagnostic Centers
8.6. Others

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.6.1. U.S.
  - 9.2.6.2. Canada
  - 9.2.6.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.6.1. Germany
  - 9.3.6.2. U.K.
  - 9.3.6.3. France
  - 9.3.6.4. Spain
  - 9.3.6.5. Italy
  - 9.3.6.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.6.1. Brazil
  - 9.4.6.2. Argentina
  - 9.4.6.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.6.1. China
  - 9.5.6.2. India
  - 9.5.6.3. Japan
  - 9.5.6.4. South Korea
  - 9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. Becton, Dickinson and Company*
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. KARL STORZ
11.3. Olympus Corporation
11.4. FUJIFILM Holdings Corporation
11.5. Boston Scientific Corporation
11.6. Richard Wolf GmbH
11.7. ATMOS MedizinTechnik GmbH & Co. KG
11.8. LABORIE MEDICAL TECHNOLOGIES CORP.
11.9. EndoMed Systems GmbH
11.10. Entermed

LIST NOT EXHAUSTIVE